

Concept-to-IND-Ready
SMALL MOLECULE Drug discovery

TURN-KEY-Integrated Model
Specializing in Target-to-IND stage projects that require one of the following:
-
Create fresh NCE IP
-
100% small molecule expertise
-
Create and expand discovery pipelines and IP portfolios
-
Custom / challenging chemistry, proteomics and in vitro assays
-
Turn-key support on program build-outs, fundraising, monetization and drug development

R&D Services

-
Custom and challenging Science solutions
-
State of the Art Facilities, Instrumentation and Software
-
70% PhD
Proprietary Cascades
-
Covalent Inhibitor Programs
-
Protein degraders
-
Cannabinoid
-
Controlled substances
-
Novel modalities
IND-Enabling

-
Development candidate to IND
-
End-to-end project management & consulting
-
Expert CMC & toxicologist
